Rephonic
Artwork for Breast Cancer Update

Breast Cancer Update

Dr. Neil Love
Breast Cancer
Antibody-Drug Conjugates
Clinical Trials
Metastatic Breast Cancer
Triple Negative Breast Cancer
ESR1 Mutations
Triple-Negative Breast Cancer
Metastatic Triple-Negative Breast Cancer
Chemotherapy
Quality Of Life
Her2-Positive Breast Cancer
Er-Positive Metastatic Breast Cancer
TDXD
Endocrine Therapy
CDK4/6 Inhibitors
Her2-Low Breast Cancer
Selective Estrogen Receptor Degraders
Hormone Receptor-Positive Breast Cancer
Cdk4-6 Inhibitors
HER2 Positive Breast Cancer

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.

PublishesWeeklyEpisodes499Founded20 years ago
Number of ListenersCategories
Health & FitnessScienceMedicine

Listen to this Podcast

Artwork for Breast Cancer Update

Latest Episodes

Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, and Dr Virginia Kaklamani from the UT Health San Antonio MD Anderson Cancer Center in San Antonio, Texas, discuss patient cases and review relevant data on the managemen... more

YouTube

Prof Bernd Kasper from the Mannheim Cancer Center in Mannheim, Germany, discusses recent updates on available and novel treatment strategies for desmoid tumors.

CME information and select publications here.

YouTube

Dr Aditya Bardia from the University of California Los Angeles and Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding the use of oral SERDs in the management of breast cancer.

CME ... more

YouTube

Dr Seth Wander from Massachusetts General Hospital in Boston discusses the role of biomarker assessment in the management of HR-positive metastatic breast cancer.

CME information and select publications here.

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)
Lung Cancer Update
Lung Cancer UpdateDr. Neil Love

Recent Guests

Aditya Bardia
Faculty guest, oncology physician-scientist
UCLA Health Johnson Comprehensive Cancer Center
Episode: Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Erica Mayer
Faculty guest, oncologist
Dana-Farber Cancer Institute
Episode: Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Virginia Borges
Dr. from University of Colorado Anschutz Medical Campus, Aurora, CO
University of Colorado Anschutz Medical Campus
Episode: ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy
Dr. Ravin Ratan
MD Anderson Cancer Center oncologist discussing desmoid tumors
MD Anderson Cancer Center
Episode: Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan
Dr. Elise Haddad
MD Anderson oncologist presenting cases
MD Anderson Cancer Center
Episode: Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan
Dr. Michael Nakazawa
Oncologist contributing to case discussions
MD Anderson Cancer Center
Episode: Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan
Jaime Carroll
Nurse practitioner
Mayo Clinic, Rochester, MN
Episode: Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway
Giuseppe Curigliano
Professor
University of Milano, European Institute of Oncology
Episode: Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway
Marie McDonnell
Director of the diabetes program
Brigham and Women's Hospital
Episode: Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway

Host

Neil Love
Host of the program; Research To Practice affiliation appears across episodes; frequently moderates expert discussions and case-based sessions.

Reviews

4.5 out of 5 stars from 94 ratings
  • Misc

    Overall wonderful updates. Listen to these while driving. Would however appreciate if the Oncology nursing series was on a separate platform or podcasts. When one is driving the podcasts roll on and I don’t want to hear the nursing discussions .It is somewhat dangerous to be messing with the podcasts while driving. (With all due respect to nursing collegues). Also in areas where there is no reception, manually skipping a talk often just causes the connection to drop.

    Apple Podcasts
    5
    worldhobo
    United States5 years ago
  • Hem/onc fellow

    I’m very grateful for these podcasts and educational videos and definitely owe majority of my hem/onc knowledge to Dr. Love! Looking forward to many more episodes across different disease sites!

    Apple Podcasts
    5
    hem/onc fellow
    United States7 years ago
  • Hemonc fellow

    Outstanding discussions! I especially like the fact they those are patient centered and touch upon some ethical/personal dilemmas! I really hope to hear annual update, thank you Dr. Love!

    Apple Podcasts
    5
    kdarbin
    United States7 years ago
  • Hem/Onc fellow

    Because of this podcast my knowledge in this field has grown substantially. It has helped me to keep up with the new data to deliver the best care to my patients. Thank you Dr. Love

    Apple Podcasts
    5
    John.KH
    United States7 years ago
  • The best

    Simply one of the best most complete and informative podcasts in any medical topic ever made. I am a pediatrician and do not treat cancer. Yet I listen to every new episode. Outstanding.

    Apple Podcasts
    5
    Bob a la sob mob
    United States7 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners value practical clinical insights and case-based discussions.
Guests and host are praised for translating complex trial data into actionable guidance.
Some feedback suggests separating nursing-focused content onto a different platform, but overall reception is highly positive among clinicians.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#26
United Arab Emirates/Science
Apple Podcasts
#167
Russia/Science
Apple Podcasts
#168
India/Science

Talking Points

Recent interactions between the hosts and their guests.

Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan
Q: When do you decide to stop therapy, and what duration do you typically target?
There is no universal stopping rule; many clinicians consider stopping after about two years if there is stable disease and good tolerance, with six months to a year as a practical starting point for treatment duration and regular reassessment for each patient.
Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
Q: What is the current stance on surgery for desmoid tumors in 2026 based on the literature discussed?
Surgery is increasingly avoided for most desmoid tumors outside of special circumstances or emergencies, with ongoing debate about location-specific indications and significant caution in FAP-associated mesenteric disease due to wound-healing and recurrence concerns.
Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
Q: What were the safety signals observed with prolonged Nirogasistat exposure, particularly regarding ovarian function?
We observed irregular periods and changes in reproductive hormones indicating ovarian toxicity, which appeared to be reversible after stopping treatment, though fertility impact could not be definitively ruled out and counseling with fertility experts was recommended.
Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
Q: Could you review the initial efficacy data in terms of response rate and duration of responses?
The DEFY trial showed a 41% response rate with Nirogasistat versus 8% with placebo, and the median PFS in the treatment group had not been reached at the time of publication, indicating meaningful activity but with ongoing uncertainty about long-term durability.
Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway
Q: How should baseline HbA1c be considered when starting PI3K inhibitors like Capivasertib or Inavolisib?
Baseline HbA1c should guide risk stratification; even patients with acceptable HbA1c can experience rapid glucose elevations during therapy, so a plan that includes metformin, GLP-1 agonists, and close monitoring is recommended, with insulin reserved for severe cases or poor control.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Breast Cancer Update

What is Breast Cancer Update about and what kind of topics does it cover?

A clinically focused series that translates cutting-edge breast cancer research into practical guidance for practicing oncologists, hematologists, and fellows. Episodes feature in-depth interviews with leading clinicians and researchers, case-based discussions, and real-world considerations around sequencing, biomarkers, and novel therapies (including SIRDs, PI3K/AKT inhibitors, ADCs, and ctDNA-guided decisions). The show repeatedly emphasizes how new data affect patient selection, treatment duration, and toxicity management, with a strong emphasis on multidisciplinary perspectives and real-world applicability that helps clinicians implement trial findings in routine care. A standout trait is the commitment to translating complex trial data... more

Where can I find podcast stats for Breast Cancer Update?

Rephonic provides a wide range of podcast stats for Breast Cancer Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Breast Cancer Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Breast Cancer Update get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Breast Cancer Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Breast Cancer Update?

Rephonic provides comprehensive predictive audience data for Breast Cancer Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Breast Cancer Update have?

To see how many followers or subscribers Breast Cancer Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Breast Cancer Update?

These podcasts share a similar audience with Breast Cancer Update:

1. Two Onc Docs
2. ASCO Daily News
3. Gastrointestinal Cancer Update
4. Oncology Today with Dr Neil Love
5. Lung Cancer Update

How many episodes of Breast Cancer Update are there?

Breast Cancer Update launched 20 years ago and published 499 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Breast Cancer Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Breast Cancer Update?

Rephonic pulls ratings and reviews for Breast Cancer Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Breast Cancer Update?

Rephonic provides full transcripts for episodes of Breast Cancer Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Breast Cancer Update?

Recent guests on Breast Cancer Update include:

1. Aditya Bardia
2. Erica Mayer
3. Virginia Borges
4. Dr. Ravin Ratan
5. Dr. Elise Haddad
6. Dr. Michael Nakazawa
7. Jaime Carroll
8. Giuseppe Curigliano

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days